C258 - Education Blitz: Multiple Sclerosis
| Event Time: | Friday May 10, 2019 3:30 pm to 4:30 pm |
| Topic(s): | MS and CNS Inflammatory Disease |
| Director(s): | Stephen Krieger MD, FAAN |
| Description: | Dr. Krieger (Mount Sinai) and Dr. Azevedo (USC) will blitz through 6 current hot topics in Multiple Sclerosis diagnosis and clinical course in this concise disease-focused program. Dr. Krieger will review clinical pitfalls in MS diagnosis in the era of the 2017 Diagnostic Criteria, provide insights into clinical course from the topographical model of MS, and examine the implications of a new laboratory biomarker for MS, neurofilament light. As MRI plays an essential role in establishing a diagnosis of MS and in monitoring MS patients over time, Dr. Azevedo will review current, clinically relevant topics in MS neuroimaging. This will include the challenges in detecting cortical lesions (which are included in the 2017 Diagnostic Criteria for MS), the assessment and clinical relevance of brain atrophy, and the utility of central vein imaging in distinguishing CNS demyelinating lesions from other causes of white matter hyperintensities. |
| Completion Message: | Participants should gain from this course an updated, nuanced view into MS diagnosis and clinical course utilizing these modern clinical, laboratory, and neuroimaging assessment techniques. |
| CME Credits: | 1 |
| Core Competencies: | Patient Care, Medical Knowledge |
| Start/End Time | Title | Faculty |
|---|---|---|
| 3:30 PM - 3:40 PM | Clinical Pitfalls in MS Diagnosis in the 2017 Diagnostic Criteria Era | Stephen Krieger MD, FAAN |
| 3:40 PM - 3:50 PM | Techniques for Detection of Cortical Lesions | Christina Azevedo MD |
| 3:50 PM - 4:00 PM | Insights into Clinical Course From the Topographical Model of MS | Stephen Krieger MD, FAAN |
| 4:00 PM - 4:10 PM | Assessment and Clinical Relevance of Brain Atrophy | Christina Azevedo MD |
| 4:10 PM - 4:20 PM | A New Laboratory Biomarker: Neurofilament Light | Stephen Krieger MD, FAAN |
| 4:20 PM - 4:30 PM | A New Imaging Biomarker: Central Vein Imaging | Christina Azevedo MD |
| Speaker | Disclosure |
|---|---|
| Christina Azevedo, MD | Dr.%20Azevedo%20has%20received%20personal%20compensation%20for%20consulting%2C%20serving%20on%20a%20scientific%20advisory%20board%2C%20speaking%2C%20or%20other%20activities%20with%20Sanofi-Genzyme%2C%20Genentech%2C%20Novartis%2C%20Biogen%20Idec. |
| Stephen Krieger, MD, FAAN | Dr. Krieger has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Acorda, Bayer, Biogen, Celgene, EMD Serono, Genentech, Genzyme, Mallinckrodt, MedDay, Novartis, Teva, and TG Therapeutics. |
Ready to register for the 2019 AAN Annual Meeting?
Related Courses
| 9:30 AM-11:30 AM |
|---|
|
C19 -
Multiple Sclerosis Overview I: Clinical Pearls
Mary Willis MD |
| 1:30 PM-3:30 PM |
|
C29 -
Multiple Sclerosis Overview II: Clinical Advances
Scott Newsome DO, FAAN |
| 7:00 AM-9:00 AM |
|---|
|
C44 -
Multiple Sclerosis Therapy: Symptom Management
Andrew Solomon MD |
| 9:15 AM-12:00 PM |
|
Presidential Plenary Session
Natalia Rost MD, MPH, FAAN, FAHA |
| 11:30 AM-6:30 PM |
|
P1 -
Poster Session 1
|
| 1:00 PM-3:00 PM |
|
C49 -
Neurology Update I: Multiple Sclerosis, Sleep, and Neuromuscular Disease
Adam Quick MD, Ralph Jozefowicz MD, FAAN |
|
C56 -
Multiple Sclerosis Therapy: Disease-modifying Treatment I
Scott Newsome DO, FAAN |
|
S6 -
MS and CNS Inflammatory Disease: Clinical Considerations I
|
| 3:30 PM-5:30 PM |
|
C73 -
Multiple Sclerosis Therapy: Disease-modifying Treatment II
John Rose MD, FAAN |
| 7:00 AM-9:00 AM |
|---|
|
C86 -
Neuromyelitis Optica Spectrum Disorders
Dean Wingerchuk MD, FAAN |
| 9:15 AM-12:00 PM |
|
Contemporary Clinical Issues Plenary Session
Randolph Marshall MD, FAAN |
| 11:30 AM-6:30 PM |
|
P2 -
Poster Session 2
|
| 1:00 PM-3:00 PM |
|
C100 -
Esclerosis Múltiple y Otras Enfermedades Inflamatorias Desmielinizantes y Autoinmunes del Sistema Nervioso Central (MS and Other Demyelinating Inflammatory and Autoimmune Central Nervous System Disorders)
Lilyana Amezcua MD, FAAN |
|
S12 -
Progressive Multiple Sclerosis
|
| 3:30 PM-5:30 PM |
|
S19 -
Child Neurology: Updates in Autism, Migraine, MS, and Stroke
|
| 7:00 AM-9:00 AM |
|---|
|
C130 -
Diagnostic Pearls in Myelitis: a Case-based Approach
Eoin Flanagan MBBCh |
| 9:15 AM-11:30 AM |
|
Clinical Trials Plenary Session
Holly Hinson MD, MCR, FAAN, Deborah Hall MD, PhD, FAAN |
| 11:30 AM-6:30 PM |
|
P3 -
Poster Session 3
|
| 1:00 PM-3:00 PM |
|
N3 -
Neuroscience in the Clinic: Stem Cells
Paul George MD, PhD, MSE, Antonio Omuro MD |
|
S26 -
MS and CNS Inflammatory Disease: Clinical Considerations II
|
| 3:30 PM-5:30 PM |
|
S31 -
MS and CNS Inflammatory Disease: Imaging
|
| 9:15 AM-11:30 AM |
|---|
|
Frontiers in Neuroscience Plenary Session
Paul George MD, PhD, MSE |
| 11:30 AM-6:30 PM |
|
P4 -
Poster Session 4
|
| 1:00 PM-3:00 PM |
|
C181 -
Treatment of Pediatric Multiple Sclerosis in the Current Era
Brenda Banwell MD, FAAN |
|
S37 -
MS Biomarkers
|
| 3:30 PM-5:30 PM |
|
Presentation of the John Dystel Prize for Multiple Sclerosis Research
|
| 3:45 PM-4:15 PM |
|
Update on the Complementary Therapies for MS: An Evidence-based Review
Vijayshree Yadav MD, FAAN |
| 11:30 AM-6:30 PM |
|---|
|
P5 -
Poster Session 5
|
| 12:00 PM-12:45 PM |
|
A "How to and Why" of the Shared Medical Appointments: A Way to Meet the Needs of the Patient and Provider While Maximizing Clinical Time
Nancy Isenberg MD, MPH, FAAN, Mary Rensel MD, FAAN |
| 1:00 PM-3:00 PM |
|
S49 -
MS Epidemiology and Risk Stratification
|
| 3:30 PM-5:30 PM |
|
S55 -
MS Basic Science
|
| 7:00 AM-9:00 AM |
|---|
|
C248 -
Multiple Sclerosis in the Trenches: Controversy and Consensus in Clinical Decision-Making
Aaron Miller MD, FAAN |
| 9:15 AM-11:30 AM |
|
Neurology Year in Review Plenary Session
Martinson Arnan MD |
| 1:00 PM-3:00 PM |
|
S56 -
MS Trials and Treatment
|
| 3:30 PM-4:30 PM |